Dear Editor,

A 62-year-old man with a medical past history of arterial hypertension and heavy smoking was ongoing radiochemotherapy for an oropharyngeal squamous cell carcinoma (cT3N0M0). Three days after the first cisplatin injection, the patient started a dry cough without fever. A nasopharyngeal swab was positive for Covid-19 (tested by PCR). A week later, he presented a marked asthenia and was referred to the emergency room. Physical examination showed fever and mild dyspnea, with a low oxygen saturation on room air. The patient was perfectly conscious, and there was no evidence of motor deficit. Chest X-ray showed bilateral lung infiltrates. The laboratory examination results were as follows: white blood cell count (WBC) 6620/μL, lymphocyte count 500/μL (Nl, 800--5000), normal neutrophil count, platelet count 101, 000/μL (Nl, 150,000--450,000), hemoglobin 12 g/dL (Nl, 13.3--16.7), CRP 45 mg/L (Nl, \< 5), normal serum creatinine, LDH 307 IU/L (Nl, \< 250), and bilirubin 0.7 mg/dL (Nl, \< 1.2).

Fourteen days after the first respiratory symptoms, he was transferred to the intensive care unit (ICU), and orotracheal intubation was required soon after admission. Anemia also deteriorated progressively with a rise of LDH level. On day 16, the patient developed acrocyanosis. Laboratory tests showed lymphocyte count 120/μL, normal neutrophil count, platelet count 145,000/μL, hemoglobin 6.9 g/dl, LDH 726 IU/L, reticulocyte count 40,000/μL (Nl, 30,000--100,000) raising to 231,000/μL 10 days later, potassium 6.78 mmol/L (Nl, 3.5--5), haptoglobin 0.13 g/L (Nl, 0.3--2), CRP 335 mg/L, normal creatinine, and bilirubin 1.3 mg/dL. Blood smear showed numerous red blood cell agglutination, schizocytes \< 1%. Direct Coombs test was positive for C3b and negative for IgG. Cold agglutinins were positive (titer 1/16384) and anti-I (titer 1/1024). Antinuclear antibodies were positive (titer 1/160), ENA screening negative, and antiphospholipid negative. A multiplex PCR testing performed on tracheal aspiration was negative for *Mycoplasma pneumoniae*, *Legionella pneumophila*, *Chlamydia pneumoniae, Adenovirus*, and *Influenza*. Serology testing was negative for HBV, HCV, and HIV, while IgG antibodies were found for EBV and CMV and IgM and IgG antibodies for *Mycoplasma pneumoniae*. Leucocytes immunophenotyping performed on peripheral blood showed lymphopenia without evidence of clonality. There was an oligoclonal pattern of gammaglobulins at serum protein electrophoresis; light chains kappa/lambda ratio was normal. The patient received 8 units of red packet cells over 1 week. At 6-week follow-up, the patient is slowly recovering from respiratory failure.

While the main target of Covid-19 remains the lung, with respiratory failure and acute respiratory distress syndrome for the most severe cases, extra-pulmonary complications are now increasingly reported. Among autoimmune manifestations, autoimmune hemolytic anemia (AIHA) is an unusual finding. Autoimmune hemolytic anemia (with warm or cold antibodies) was recently described in 7 patients with Covid-19 disease \[[@CR1], [@CR2]\]. The delay between Covid-19 and hemolytic manifestations ranged from 4 to 13 days. Four patients had indolent B lymphoid malignancy either already known or discovered at the time of hemolytic episode. The chronological sequence in our case suggests that Covid-19 was the causal factor for AIHA. Temporal events and exclusion of other potential causes support this hypothesis. Indeed, our patient had a history of oropharyngeal carcinoma which is not usually considered as a triggering factor for autoimmune hemolytic anemia. The interpretation of *Mycoplasma pneumonia* serology should also be extremely careful, as IgM antibodies do not mandatory indicate a recent infection \[[@CR3]\]. In our case, PCR testing was negative on the sputum, and there was no significant increase in IgG antibody titer over time. Among other hematological complications of Covid-19 infection, autoimmune thrombocytopenia and antiphospholipid syndrome were also described, but not present in our observation \[[@CR1], [@CR4], [@CR5]\].
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